Quantcast
Channel: Crain's Detroit Business
Viewing all articles
Browse latest Browse all 346

Gemphire Therapeutics delays IPO over uncertainty caused by Brexit

$
0
0
Tom Henderson - The initial public offering for Northville-based Gemphire Therapeutics Inc., which had been scheduled for the Nasdaq Stock Exchange on Thursday, is now likely to happen sometime this week, according to the website iposcoop.com. Company officials declined to comment because of a quiet period mandated by the U.S. Securities and Exchange Commission, but word in the local tech community is the company decided to delay the offering over market uncertainty about Thursday's vote by British citizens

Viewing all articles
Browse latest Browse all 346

Trending Articles